Dova Pharmaceuticals Inc. (DOVA) Stock Price & Overview

NASDAQ:DOVA

28.04
+0.04 (+0.14%)
At close: Nov 11, 2019
28.04
0 (0%)
After Hours: 11/11/2019, 9:00:22 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Forecast Earnings Financials Ownership News

The current stock price of DOVA is 28.04 null. Today DOVA is up by 0.14%. In the past month the price decreased by -0.25%. In the past year, price increased by 80.9%.

DOVA Key Statistics

52-Week Range5.62 - 28.54
Current DOVA stock price positioned within its 52-week range.
1-Month Range27.93 - 28.54
Current DOVA stock price positioned within its 1-month range.
Market Cap
807.608M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-2.56
Dividend Yield
N/A

DOVA Stock Performance

Today
+0.14%
1 Week
-0.07%
1 Month
-0.25%
3 Months
+93.11%
Longer-term
6 Months +160.60%
1 Year +80.90%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

DOVA Stock Chart

Dova Pharmaceuticals Inc. / DOVA Daily stock chart

DOVA Technical Analysis

ChartMill assigns a technical rating of 8 / 10 to DOVA. When comparing the yearly performance of all stocks, DOVA is one of the better performing stocks in the market, outperforming 98.83% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating
DOVA Full Technical Analysis Report

DOVA Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to DOVA. The financial health of DOVA is average, but there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
DOVA Full Fundamental Analysis Report

DOVA Earnings

Next Earnings DateN/A
Last Earnings DateN/A
DOVA Earnings History

DOVA Forecast & Estimates


Analysts
Analysts76
Price TargetN/A
EPS Next Y6.15%
Revenue Next YearN/A
DOVA Forecast & Estimates

DOVA Financial Highlights

Over the last trailing twelve months DOVA reported a non-GAAP Earnings per Share(EPS) of -2.5599999999999996. The EPS decreased by -30.61% compared to the year before.


Income Statements
Revenue(TTM)13.73M
Net Income(TTM)-74.06M
Industry RankSector Rank
PM (TTM) -539.32%
ROA -93.81%
ROE N/A
Debt/Equity 0.9
Chartmill High Growth Momentum
EPS Q2Q%14.29%
Sales Q2Q%15.16%
EPS 1Y (TTM)-30.61%
Revenue 1Y (TTM)82.78%
DOVA financials

DOVA Ownership

Ownership
Inst Owners33.03%
Shares28.80M
Float7.81M
Ins Owners43.01%
Short Float %N/A
Short RatioN/A
DOVA Ownership

About DOVA

Company Profile

Dova Pharmaceuticals, Inc. is a pharmaceutical company. It focuses on acquiring, developing and commercializing drug candidates for thrombocytopenia diseases. The company's drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist which are in clinical stage. Dova Pharmaceuticals, Inc. is based in Durham, North Carolina.

Company Info

Dova Pharmaceuticals Inc.

240 Leigh Farm Road Suite 245

Durham NC 27707

CEO: David Zaccardelli

Phone: 919-748-5975

Dova Pharmaceuticals Inc. / DOVA FAQ

What does DOVA do?

Dova Pharmaceuticals, Inc. is a pharmaceutical company. It focuses on acquiring, developing and commercializing drug candidates for thrombocytopenia diseases. The company's drug candidate includes avatrombopag, an orally administered thrombopoietin receptor agonist which are in clinical stage. Dova Pharmaceuticals, Inc. is based in Durham, North Carolina.


What is the stock price of Dova Pharmaceuticals Inc. today?

The current stock price of DOVA is 28.04 null. The price increased by 0.14% in the last trading session.


What is the dividend status of Dova Pharmaceuticals Inc.?

DOVA does not pay a dividend.


How is the ChartMill rating for Dova Pharmaceuticals Inc.?

DOVA has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


Can you provide the PE ratio for DOVA stock?

Dova Pharmaceuticals Inc. (DOVA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.56).